Global Doxorubicin Hydrochloride Supply, Demand and Key Producers, 2025-2031
Page: 96
Published Date: 14 Apr 2025
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Doxorubicin Hydrochloride market size is expected to reach $ 93.3 million by 2031, rising at a market growth of 6.5% CAGR during the forecast period (2025-2031).
Doxorubicin hydrochloride is a type of chemotherapy drug called an anthracycline. It blocks an enzyme called topoisomerase II, which cuts and repairs tangled strands of DNA. This stops or slows the growth of cancer cells and other rapidly dividing cells.1
The global core manufacturers of Doxorubicin Hydrochloride include Pfizer, Teva and Viatris. The top three companies have a market share of about 50%. Asia Pacific is the world's largest market for Doxorubicin Hydrochloride with a market share of about 39%, followed by North America and Europe with a market share of 30% and 27%, respectively. In terms of product type, 10mg is the largest segment with approximately 32% market share. In terms of application, Lung Cancer is the largest downstream segment, accounting for about 24% of the market.
This report studies the global Doxorubicin Hydrochloride production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Doxorubicin Hydrochloride and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2024 as the base year. This report explores demand trends and competition, as well as details the characteristics of Doxorubicin Hydrochloride that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Doxorubicin Hydrochloride total production and demand, 2020-2031, (K Units)
Global Doxorubicin Hydrochloride total production value, 2020-2031, (USD Million)
Global Doxorubicin Hydrochloride production by region & country, production, value, CAGR, 2020-2031, (USD Million) & (K Units), (based on production site)
Global Doxorubicin Hydrochloride consumption by region & country, CAGR, 2020-2031 & (K Units)
U.S. VS China: Doxorubicin Hydrochloride domestic production, consumption, key domestic manufacturers and share
Global Doxorubicin Hydrochloride production by manufacturer, production, price, value and market share 2020-2025, (USD Million) & (K Units)
Global Doxorubicin Hydrochloride production by Type, production, value, CAGR, 2020-2031, (USD Million) & (K Units)
Global Doxorubicin Hydrochloride production by Application, production, value, CAGR, 2020-2031, (USD Million) & (K Units)
This report profiles key players in the global Doxorubicin Hydrochloride market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Teva, Viatris, Medac GmbH, Fresenius Kabi, Sun Pharmaceutical, Shanxi PUDE Pharmaceutical, Zhejiang Hisun (HanHui Pharmaceuticals), Shenzhen Main Luck Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Doxorubicin Hydrochloride market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2020-2031 by year with 2024 as the base year, 2025 as the estimate year, and 2026-2031 as the forecast year.
Global Doxorubicin Hydrochloride Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Doxorubicin Hydrochloride Market, Segmentation by Type:
10mg
20mg
50mg
200mg
Others
Global Doxorubicin Hydrochloride Market, Segmentation by Application:
Breast Cancer
Acute Leukemia
Lung Cancer
Malignant Lymphoma
Others
Companies Profiled:
Pfizer
Teva
Viatris
Medac GmbH
Fresenius Kabi
Sun Pharmaceutical
Shanxi PUDE Pharmaceutical
Zhejiang Hisun (HanHui Pharmaceuticals)
Shenzhen Main Luck Pharmaceuticals
Key Questions Answered:
1. How big is the global Doxorubicin Hydrochloride market?
2. What is the demand of the global Doxorubicin Hydrochloride market?
3. What is the year over year growth of the global Doxorubicin Hydrochloride market?
4. What is the production and production value of the global Doxorubicin Hydrochloride market?
5. Who are the key producers in the global Doxorubicin Hydrochloride market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Doxorubicin Hydrochloride Introduction
1.2 World Doxorubicin Hydrochloride Supply & Forecast
1.2.1 World Doxorubicin Hydrochloride Production Value (2020 & 2024 & 2031)
1.2.2 World Doxorubicin Hydrochloride Production (2020-2031)
1.2.3 World Doxorubicin Hydrochloride Pricing Trends (2020-2031)
1.3 World Doxorubicin Hydrochloride Production by Region (Based on Production Site)
1.3.1 World Doxorubicin Hydrochloride Production Value by Region (2020-2031)
1.3.2 World Doxorubicin Hydrochloride Production by Region (2020-2031)
1.3.3 World Doxorubicin Hydrochloride Average Price by Region (2020-2031)
1.3.4 North America Doxorubicin Hydrochloride Production (2020-2031)
1.3.5 Europe Doxorubicin Hydrochloride Production (2020-2031)
1.3.6 China Doxorubicin Hydrochloride Production (2020-2031)
1.3.7 Japan Doxorubicin Hydrochloride Production (2020-2031)
1.4 Market Drivers, Restraints and Trends
1.4.1 Doxorubicin Hydrochloride Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Doxorubicin Hydrochloride Major Market Trends
2.1 World Doxorubicin Hydrochloride Demand (2020-2031)
2.2 World Doxorubicin Hydrochloride Consumption by Region
2.2.1 World Doxorubicin Hydrochloride Consumption by Region (2020-2025)
2.2.2 World Doxorubicin Hydrochloride Consumption Forecast by Region (2026-2031)
2.3 United States Doxorubicin Hydrochloride Consumption (2020-2031)
2.4 China Doxorubicin Hydrochloride Consumption (2020-2031)
2.5 Europe Doxorubicin Hydrochloride Consumption (2020-2031)
2.6 Japan Doxorubicin Hydrochloride Consumption (2020-2031)
2.7 South Korea Doxorubicin Hydrochloride Consumption (2020-2031)
2.8 ASEAN Doxorubicin Hydrochloride Consumption (2020-2031)
2.9 India Doxorubicin Hydrochloride Consumption (2020-2031)
3.1 World Doxorubicin Hydrochloride Production Value by Manufacturer (2020-2025)
3.2 World Doxorubicin Hydrochloride Production by Manufacturer (2020-2025)
3.3 World Doxorubicin Hydrochloride Average Price by Manufacturer (2020-2025)
3.4 Doxorubicin Hydrochloride Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Doxorubicin Hydrochloride Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Doxorubicin Hydrochloride in 2024
3.5.3 Global Concentration Ratios (CR8) for Doxorubicin Hydrochloride in 2024
3.6 Doxorubicin Hydrochloride Market: Overall Company Footprint Analysis
3.6.1 Doxorubicin Hydrochloride Market: Region Footprint
3.6.2 Doxorubicin Hydrochloride Market: Company Product Type Footprint
3.6.3 Doxorubicin Hydrochloride Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Doxorubicin Hydrochloride Production Value Comparison
4.1.1 United States VS China: Doxorubicin Hydrochloride Production Value Comparison (2020 & 2024 & 2031)
4.1.2 United States VS China: Doxorubicin Hydrochloride Production Value Market Share Comparison (2020 & 2024 & 2031)
4.2 United States VS China: Doxorubicin Hydrochloride Production Comparison
4.2.1 United States VS China: Doxorubicin Hydrochloride Production Comparison (2020 & 2024 & 2031)
4.2.2 United States VS China: Doxorubicin Hydrochloride Production Market Share Comparison (2020 & 2024 & 2031)
4.3 United States VS China: Doxorubicin Hydrochloride Consumption Comparison
4.3.1 United States VS China: Doxorubicin Hydrochloride Consumption Comparison (2020 & 2024 & 2031)
4.3.2 United States VS China: Doxorubicin Hydrochloride Consumption Market Share Comparison (2020 & 2024 & 2031)
4.4 United States Based Doxorubicin Hydrochloride Manufacturers and Market Share, 2020-2025
4.4.1 United States Based Doxorubicin Hydrochloride Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Doxorubicin Hydrochloride Production Value (2020-2025)
4.4.3 United States Based Manufacturers Doxorubicin Hydrochloride Production (2020-2025)
4.5 China Based Doxorubicin Hydrochloride Manufacturers and Market Share
4.5.1 China Based Doxorubicin Hydrochloride Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Doxorubicin Hydrochloride Production Value (2020-2025)
4.5.3 China Based Manufacturers Doxorubicin Hydrochloride Production (2020-2025)
4.6 Rest of World Based Doxorubicin Hydrochloride Manufacturers and Market Share, 2020-2025
4.6.1 Rest of World Based Doxorubicin Hydrochloride Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Doxorubicin Hydrochloride Production Value (2020-2025)
4.6.3 Rest of World Based Manufacturers Doxorubicin Hydrochloride Production (2020-2025)
5.1 World Doxorubicin Hydrochloride Market Size Overview by Type: 2020 VS 2024 VS 2031
5.2 Segment Introduction by Type
5.2.1 10mg
5.2.2 20mg
5.2.3 50mg
5.2.4 200mg
5.2.5 Others
5.3 Market Segment by Type
5.3.1 World Doxorubicin Hydrochloride Production by Type (2020-2031)
5.3.2 World Doxorubicin Hydrochloride Production Value by Type (2020-2031)
5.3.3 World Doxorubicin Hydrochloride Average Price by Type (2020-2031)
6.1 World Doxorubicin Hydrochloride Market Size Overview by Application: 2020 VS 2024 VS 2031
6.2 Segment Introduction by Application
6.2.1 Breast Cancer
6.2.2 Acute Leukemia
6.2.3 Lung Cancer
6.2.4 Malignant Lymphoma
6.2.5 Others
6.3 Market Segment by Application
6.3.1 World Doxorubicin Hydrochloride Production by Application (2020-2031)
6.3.2 World Doxorubicin Hydrochloride Production Value by Application (2020-2031)
6.3.3 World Doxorubicin Hydrochloride Average Price by Application (2020-2031)
7.1 Pfizer
7.1.1 Pfizer Details
7.1.2 Pfizer Major Business
7.1.3 Pfizer Doxorubicin Hydrochloride Product and Services
7.1.4 Pfizer Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.1.5 Pfizer Recent Developments/Updates
7.1.6 Pfizer Competitive Strengths & Weaknesses
7.2 Teva
7.2.1 Teva Details
7.2.2 Teva Major Business
7.2.3 Teva Doxorubicin Hydrochloride Product and Services
7.2.4 Teva Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.2.5 Teva Recent Developments/Updates
7.2.6 Teva Competitive Strengths & Weaknesses
7.3 Viatris
7.3.1 Viatris Details
7.3.2 Viatris Major Business
7.3.3 Viatris Doxorubicin Hydrochloride Product and Services
7.3.4 Viatris Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.3.5 Viatris Recent Developments/Updates
7.3.6 Viatris Competitive Strengths & Weaknesses
7.4 Medac GmbH
7.4.1 Medac GmbH Details
7.4.2 Medac GmbH Major Business
7.4.3 Medac GmbH Doxorubicin Hydrochloride Product and Services
7.4.4 Medac GmbH Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.4.5 Medac GmbH Recent Developments/Updates
7.4.6 Medac GmbH Competitive Strengths & Weaknesses
7.5 Fresenius Kabi
7.5.1 Fresenius Kabi Details
7.5.2 Fresenius Kabi Major Business
7.5.3 Fresenius Kabi Doxorubicin Hydrochloride Product and Services
7.5.4 Fresenius Kabi Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.5.5 Fresenius Kabi Recent Developments/Updates
7.5.6 Fresenius Kabi Competitive Strengths & Weaknesses
7.6 Sun Pharmaceutical
7.6.1 Sun Pharmaceutical Details
7.6.2 Sun Pharmaceutical Major Business
7.6.3 Sun Pharmaceutical Doxorubicin Hydrochloride Product and Services
7.6.4 Sun Pharmaceutical Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.6.5 Sun Pharmaceutical Recent Developments/Updates
7.6.6 Sun Pharmaceutical Competitive Strengths & Weaknesses
7.7 Shanxi PUDE Pharmaceutical
7.7.1 Shanxi PUDE Pharmaceutical Details
7.7.2 Shanxi PUDE Pharmaceutical Major Business
7.7.3 Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Product and Services
7.7.4 Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.7.5 Shanxi PUDE Pharmaceutical Recent Developments/Updates
7.7.6 Shanxi PUDE Pharmaceutical Competitive Strengths & Weaknesses
7.8 Zhejiang Hisun (HanHui Pharmaceuticals)
7.8.1 Zhejiang Hisun (HanHui Pharmaceuticals) Details
7.8.2 Zhejiang Hisun (HanHui Pharmaceuticals) Major Business
7.8.3 Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Product and Services
7.8.4 Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.8.5 Zhejiang Hisun (HanHui Pharmaceuticals) Recent Developments/Updates
7.8.6 Zhejiang Hisun (HanHui Pharmaceuticals) Competitive Strengths & Weaknesses
7.9 Shenzhen Main Luck Pharmaceuticals
7.9.1 Shenzhen Main Luck Pharmaceuticals Details
7.9.2 Shenzhen Main Luck Pharmaceuticals Major Business
7.9.3 Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Product and Services
7.9.4 Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Production, Price, Value, Gross Margin and Market Share (2020-2025)
7.9.5 Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates
7.9.6 Shenzhen Main Luck Pharmaceuticals Competitive Strengths & Weaknesses
8.1 Doxorubicin Hydrochloride Industry Chain
8.2 Doxorubicin Hydrochloride Upstream Analysis
8.2.1 Doxorubicin Hydrochloride Core Raw Materials
8.2.2 Main Manufacturers of Doxorubicin Hydrochloride Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Doxorubicin Hydrochloride Production Mode
8.6 Doxorubicin Hydrochloride Procurement Model
8.7 Doxorubicin Hydrochloride Industry Sales Model and Sales Channels
8.7.1 Doxorubicin Hydrochloride Sales Model
8.7.2 Doxorubicin Hydrochloride Typical Distributors
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Doxorubicin Hydrochloride Production Value by Region (2020, 2024 and 2031) & (USD Million)
Table 2. World Doxorubicin Hydrochloride Production Value by Region (2020-2025) & (USD Million)
Table 3. World Doxorubicin Hydrochloride Production Value by Region (2026-2031) & (USD Million)
Table 4. World Doxorubicin Hydrochloride Production Value Market Share by Region (2020-2025)
Table 5. World Doxorubicin Hydrochloride Production Value Market Share by Region (2026-2031)
Table 6. World Doxorubicin Hydrochloride Production by Region (2020-2025) & (K Units)
Table 7. World Doxorubicin Hydrochloride Production by Region (2026-2031) & (K Units)
Table 8. World Doxorubicin Hydrochloride Production Market Share by Region (2020-2025)
Table 9. World Doxorubicin Hydrochloride Production Market Share by Region (2026-2031)
Table 10. World Doxorubicin Hydrochloride Average Price by Region (2020-2025) & (US$/Unit)
Table 11. World Doxorubicin Hydrochloride Average Price by Region (2026-2031) & (US$/Unit)
Table 12. Doxorubicin Hydrochloride Major Market Trends
Table 13. World Doxorubicin Hydrochloride Consumption Growth Rate Forecast by Region (2020 & 2024 & 2031) & (K Units)
Table 14. World Doxorubicin Hydrochloride Consumption by Region (2020-2025) & (K Units)
Table 15. World Doxorubicin Hydrochloride Consumption Forecast by Region (2026-2031) & (K Units)
Table 16. World Doxorubicin Hydrochloride Production Value by Manufacturer (2020-2025) & (USD Million)
Table 17. Production Value Market Share of Key Doxorubicin Hydrochloride Producers in 2024
Table 18. World Doxorubicin Hydrochloride Production by Manufacturer (2020-2025) & (K Units)
Table 19. Production Market Share of Key Doxorubicin Hydrochloride Producers in 2024
Table 20. World Doxorubicin Hydrochloride Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 21. Global Doxorubicin Hydrochloride Company Evaluation Quadrant
Table 22. World Doxorubicin Hydrochloride Industry Rank of Major Manufacturers, Based on Production Value in 2024
Table 23. Head Office and Doxorubicin Hydrochloride Production Site of Key Manufacturer
Table 24. Doxorubicin Hydrochloride Market: Company Product Type Footprint
Table 25. Doxorubicin Hydrochloride Market: Company Product Application Footprint
Table 26. Doxorubicin Hydrochloride Competitive Factors
Table 27. Doxorubicin Hydrochloride New Entrant and Capacity Expansion Plans
Table 28. Doxorubicin Hydrochloride Mergers & Acquisitions Activity
Table 29. United States VS China Doxorubicin Hydrochloride Production Value Comparison, (2020 & 2024 & 2031) & (USD Million)
Table 30. United States VS China Doxorubicin Hydrochloride Production Comparison, (2020 & 2024 & 2031) & (K Units)
Table 31. United States VS China Doxorubicin Hydrochloride Consumption Comparison, (2020 & 2024 & 2031) & (K Units)
Table 32. United States Based Doxorubicin Hydrochloride Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Doxorubicin Hydrochloride Production Value, (2020-2025) & (USD Million)
Table 34. United States Based Manufacturers Doxorubicin Hydrochloride Production Value Market Share (2020-2025)
Table 35. United States Based Manufacturers Doxorubicin Hydrochloride Production (2020-2025) & (K Units)
Table 36. United States Based Manufacturers Doxorubicin Hydrochloride Production Market Share (2020-2025)
Table 37. China Based Doxorubicin Hydrochloride Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Doxorubicin Hydrochloride Production Value, (2020-2025) & (USD Million)
Table 39. China Based Manufacturers Doxorubicin Hydrochloride Production Value Market Share (2020-2025)
Table 40. China Based Manufacturers Doxorubicin Hydrochloride Production, (2020-2025) & (K Units)
Table 41. China Based Manufacturers Doxorubicin Hydrochloride Production Market Share (2020-2025)
Table 42. Rest of World Based Doxorubicin Hydrochloride Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Doxorubicin Hydrochloride Production Value, (2020-2025) & (USD Million)
Table 44. Rest of World Based Manufacturers Doxorubicin Hydrochloride Production Value Market Share (2020-2025)
Table 45. Rest of World Based Manufacturers Doxorubicin Hydrochloride Production, (2020-2025) & (K Units)
Table 46. Rest of World Based Manufacturers Doxorubicin Hydrochloride Production Market Share (2020-2025)
Table 47. World Doxorubicin Hydrochloride Production Value by Type, (USD Million), 2020 & 2024 & 2031
Table 48. World Doxorubicin Hydrochloride Production by Type (2020-2025) & (K Units)
Table 49. World Doxorubicin Hydrochloride Production by Type (2026-2031) & (K Units)
Table 50. World Doxorubicin Hydrochloride Production Value by Type (2020-2025) & (USD Million)
Table 51. World Doxorubicin Hydrochloride Production Value by Type (2026-2031) & (USD Million)
Table 52. World Doxorubicin Hydrochloride Average Price by Type (2020-2025) & (US$/Unit)
Table 53. World Doxorubicin Hydrochloride Average Price by Type (2026-2031) & (US$/Unit)
Table 54. World Doxorubicin Hydrochloride Production Value by Application, (USD Million), 2020 & 2024 & 2031
Table 55. World Doxorubicin Hydrochloride Production by Application (2020-2025) & (K Units)
Table 56. World Doxorubicin Hydrochloride Production by Application (2026-2031) & (K Units)
Table 57. World Doxorubicin Hydrochloride Production Value by Application (2020-2025) & (USD Million)
Table 58. World Doxorubicin Hydrochloride Production Value by Application (2026-2031) & (USD Million)
Table 59. World Doxorubicin Hydrochloride Average Price by Application (2020-2025) & (US$/Unit)
Table 60. World Doxorubicin Hydrochloride Average Price by Application (2026-2031) & (US$/Unit)
Table 61. Pfizer Basic Information, Manufacturing Base and Competitors
Table 62. Pfizer Major Business
Table 63. Pfizer Doxorubicin Hydrochloride Product and Services
Table 64. Pfizer Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 65. Pfizer Recent Developments/Updates
Table 66. Pfizer Competitive Strengths & Weaknesses
Table 67. Teva Basic Information, Manufacturing Base and Competitors
Table 68. Teva Major Business
Table 69. Teva Doxorubicin Hydrochloride Product and Services
Table 70. Teva Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 71. Teva Recent Developments/Updates
Table 72. Teva Competitive Strengths & Weaknesses
Table 73. Viatris Basic Information, Manufacturing Base and Competitors
Table 74. Viatris Major Business
Table 75. Viatris Doxorubicin Hydrochloride Product and Services
Table 76. Viatris Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Viatris Recent Developments/Updates
Table 78. Viatris Competitive Strengths & Weaknesses
Table 79. Medac GmbH Basic Information, Manufacturing Base and Competitors
Table 80. Medac GmbH Major Business
Table 81. Medac GmbH Doxorubicin Hydrochloride Product and Services
Table 82. Medac GmbH Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Medac GmbH Recent Developments/Updates
Table 84. Medac GmbH Competitive Strengths & Weaknesses
Table 85. Fresenius Kabi Basic Information, Manufacturing Base and Competitors
Table 86. Fresenius Kabi Major Business
Table 87. Fresenius Kabi Doxorubicin Hydrochloride Product and Services
Table 88. Fresenius Kabi Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 89. Fresenius Kabi Recent Developments/Updates
Table 90. Fresenius Kabi Competitive Strengths & Weaknesses
Table 91. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 92. Sun Pharmaceutical Major Business
Table 93. Sun Pharmaceutical Doxorubicin Hydrochloride Product and Services
Table 94. Sun Pharmaceutical Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 95. Sun Pharmaceutical Recent Developments/Updates
Table 96. Sun Pharmaceutical Competitive Strengths & Weaknesses
Table 97. Shanxi PUDE Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 98. Shanxi PUDE Pharmaceutical Major Business
Table 99. Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Product and Services
Table 100. Shanxi PUDE Pharmaceutical Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 101. Shanxi PUDE Pharmaceutical Recent Developments/Updates
Table 102. Shanxi PUDE Pharmaceutical Competitive Strengths & Weaknesses
Table 103. Zhejiang Hisun (HanHui Pharmaceuticals) Basic Information, Manufacturing Base and Competitors
Table 104. Zhejiang Hisun (HanHui Pharmaceuticals) Major Business
Table 105. Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Product and Services
Table 106. Zhejiang Hisun (HanHui Pharmaceuticals) Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Zhejiang Hisun (HanHui Pharmaceuticals) Recent Developments/Updates
Table 108. Zhejiang Hisun (HanHui Pharmaceuticals) Competitive Strengths & Weaknesses
Table 109. Shenzhen Main Luck Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Shenzhen Main Luck Pharmaceuticals Major Business
Table 111. Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Product and Services
Table 112. Shenzhen Main Luck Pharmaceuticals Doxorubicin Hydrochloride Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2020-2025)
Table 113. Shenzhen Main Luck Pharmaceuticals Recent Developments/Updates
Table 114. Shenzhen Main Luck Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Global Key Players of Doxorubicin Hydrochloride Upstream (Raw Materials)
Table 116. Global Doxorubicin Hydrochloride Typical Customers
Table 117. Doxorubicin Hydrochloride Typical Distributors
List of Figures
Figure 1. Doxorubicin Hydrochloride Picture
Figure 2. World Doxorubicin Hydrochloride Production Value: 2020 & 2024 & 2031, (USD Million)
Figure 3. World Doxorubicin Hydrochloride Production Value and Forecast (2020-2031) & (USD Million)
Figure 4. World Doxorubicin Hydrochloride Production (2020-2031) & (K Units)
Figure 5. World Doxorubicin Hydrochloride Average Price (2020-2031) & (US$/Unit)
Figure 6. World Doxorubicin Hydrochloride Production Value Market Share by Region (2020-2031)
Figure 7. World Doxorubicin Hydrochloride Production Market Share by Region (2020-2031)
Figure 8. North America Doxorubicin Hydrochloride Production (2020-2031) & (K Units)
Figure 9. Europe Doxorubicin Hydrochloride Production (2020-2031) & (K Units)
Figure 10. China Doxorubicin Hydrochloride Production (2020-2031) & (K Units)
Figure 11. Japan Doxorubicin Hydrochloride Production (2020-2031) & (K Units)
Figure 12. Doxorubicin Hydrochloride Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Doxorubicin Hydrochloride Consumption (2020-2031) & (K Units)
Figure 15. World Doxorubicin Hydrochloride Consumption Market Share by Region (2020-2031)
Figure 16. United States Doxorubicin Hydrochloride Consumption (2020-2031) & (K Units)
Figure 17. China Doxorubicin Hydrochloride Consumption (2020-2031) & (K Units)
Figure 18. Europe Doxorubicin Hydrochloride Consumption (2020-2031) & (K Units)
Figure 19. Japan Doxorubicin Hydrochloride Consumption (2020-2031) & (K Units)
Figure 20. South Korea Doxorubicin Hydrochloride Consumption (2020-2031) & (K Units)
Figure 21. ASEAN Doxorubicin Hydrochloride Consumption (2020-2031) & (K Units)
Figure 22. India Doxorubicin Hydrochloride Consumption (2020-2031) & (K Units)
Figure 23. Producer Shipments of Doxorubicin Hydrochloride by Manufacturer Revenue ($MM) and Market Share (%): 2024
Figure 24. Global Four-firm Concentration Ratios (CR4) for Doxorubicin Hydrochloride Markets in 2024
Figure 25. Global Four-firm Concentration Ratios (CR8) for Doxorubicin Hydrochloride Markets in 2024
Figure 26. United States VS China: Doxorubicin Hydrochloride Production Value Market Share Comparison (2020 & 2024 & 2031)
Figure 27. United States VS China: Doxorubicin Hydrochloride Production Market Share Comparison (2020 & 2024 & 2031)
Figure 28. United States VS China: Doxorubicin Hydrochloride Consumption Market Share Comparison (2020 & 2024 & 2031)
Figure 29. United States Based Manufacturers Doxorubicin Hydrochloride Production Market Share 2024
Figure 30. China Based Manufacturers Doxorubicin Hydrochloride Production Market Share 2024
Figure 31. Rest of World Based Manufacturers Doxorubicin Hydrochloride Production Market Share 2024
Figure 32. World Doxorubicin Hydrochloride Production Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 33. World Doxorubicin Hydrochloride Production Value Market Share by Type in 2024
Figure 34. 10mg
Figure 35. 20mg
Figure 36. 50mg
Figure 37. 200mg
Figure 38. Others
Figure 39. World Doxorubicin Hydrochloride Production Market Share by Type (2020-2031)
Figure 40. World Doxorubicin Hydrochloride Production Value Market Share by Type (2020-2031)
Figure 41. World Doxorubicin Hydrochloride Average Price by Type (2020-2031) & (US$/Unit)
Figure 42. World Doxorubicin Hydrochloride Production Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 43. World Doxorubicin Hydrochloride Production Value Market Share by Application in 2024
Figure 44. Breast Cancer
Figure 45. Acute Leukemia
Figure 46. Lung Cancer
Figure 47. Malignant Lymphoma
Figure 48. Others
Figure 49. World Doxorubicin Hydrochloride Production Market Share by Application (2020-2031)
Figure 50. World Doxorubicin Hydrochloride Production Value Market Share by Application (2020-2031)
Figure 51. World Doxorubicin Hydrochloride Average Price by Application (2020-2031) & (US$/Unit)
Figure 52. Doxorubicin Hydrochloride Industry Chain
Figure 53. Doxorubicin Hydrochloride Procurement Model
Figure 54. Doxorubicin Hydrochloride Sales Model
Figure 55. Doxorubicin Hydrochloride Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Pfizer Teva Viatris Medac GmbH Fresenius Kabi Sun Pharmaceutical Shanxi PUDE Pharmaceutical Zhejiang Hisun (HanHui Pharmaceuticals) Shenzhen Main Luck Pharmaceuticals
Related Reports
13 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
